allopregnane-3,20-diol has been researched along with Learning Disabilities in 1 studies
*Learning Disabilities: Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Backstrom, T; Birzniece, V; Johansson, IM; Lundgren, P; Turkmen, S; Zingmark, E | 1 |
1 other study(ies) available for allopregnane-3,20-diol and Learning Disabilities
| Article | Year |
|---|---|
3beta-20beta-dihydroxy-5alpha-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cerebral Cortex; Chlorides; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Synergism; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Learning Disabilities; Male; Maze Learning; Pregnanediol; Pregnanolone; Radioimmunoassay; Rats; Rats, Wistar; Reaction Time; Statistics, Nonparametric; Time Factors | 2004 |